Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,940 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes.
Zarranz-Ventura J, Parrado-Carrillo A, Nguyen V, Sararols L, Garay-Aramburu G, Puzo M, Arruabarrena C, Figueras-Roca M, Gillies MC, Casaroli-Marano RP; from the writing committee of the Fight Retinal Blindness Spain (FRB! Spain) Users Group. Zarranz-Ventura J, et al. Among authors: nguyen v. Clin Exp Ophthalmol. 2022 Apr;50(3):312-324. doi: 10.1111/ceo.14054. Epub 2022 Feb 20. Clin Exp Ophthalmol. 2022. PMID: 35106882 Free article.
Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et al.: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2016;123:1751-1761).
Gillies MC, Daien V, Nguyen V, Barthelmes D. Gillies MC, et al. Among authors: nguyen v. Ophthalmology. 2017 Mar;124(3):e31-e32. doi: 10.1016/j.ophtha.2016.05.054. Ophthalmology. 2017. PMID: 28219517 No abstract available.
Short-term vision gains at 12 weeks correlate with long-term vision gains at 2 years: results from the BEVORDEX randomised clinical trial of bevacizumab versus dexamethasone implants for diabetic macular oedema.
Mehta H, Fraser-Bell S, Nguyen V, Lim LL, Gillies MC. Mehta H, et al. Among authors: nguyen v. Br J Ophthalmol. 2018 Apr;102(4):479-482. doi: 10.1136/bjophthalmol-2017-310737. Epub 2017 Aug 4. Br J Ophthalmol. 2018. PMID: 28779007 Clinical Trial.
RANIBIZUMAB AND AFLIBERCEPT FOR THE TREATMENT OF PIGMENT EPITHELIAL DETACHMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Data from an Observational Study.
Vaze A, Nguyen V, Daien V, Arnold JJ, Young SH, Cheung CM, Lamoureux E, Bhargava M, Barthelmes D, Gillies MC; Fight Retinal Blindness Study Group. Vaze A, et al. Among authors: nguyen v. Retina. 2018 Oct;38(10):1954-1961. doi: 10.1097/IAE.0000000000001815. Retina. 2018. PMID: 28820848 Free article.
Clinical and social characteristics associated with reduced visual acuity at presentation in Australian patients with neovascular age-related macular degeneration: a prospective study from a long-term observational data set. The Fight Retinal Blindness! Project.
Nguyen V, Daien V, Guymer RH, McAllister IL, Morlet N, Barthelmes D, Gillies MC. Nguyen V, et al. Clin Exp Ophthalmol. 2018 Apr;46(3):266-274. doi: 10.1111/ceo.13038. Epub 2017 Oct 4. Clin Exp Ophthalmol. 2018. PMID: 28842956
4,940 results